COFCO TECH(SZ:000930) Xuan Gu Bao·2025-09-23 23:30Industry Insights - The launch of D-alloheptulose, the first domestic product of its kind, fills a gap in the high-end functional sugar market in China and signifies a breakthrough in biomanufacturing technology [1] - D-alloheptulose is recognized for its low energy content and non-glycemic properties, making it a potential substitute for traditional food sweeteners, with safety approvals from multiple countries [1] - The global market for D-alloheptulose is projected to reach $147 million by 2024, with an expected compound annual growth rate (CAGR) of 14% from 2025 to 2034 [1] Company Developments - Bailong Chuangyuan is noted as the first company in China to achieve industrial-scale production of D-alloheptulose [3] - Baolingbao is one of the earliest companies to invest in D-alloheptulose projects, currently operating over 5,000 tons of production capacity, with plans to expand to 30,000 tons by 2026 [3] Market Dynamics - Currently, all D-alloheptulose products from China are exported, but domestic applications are expected to accelerate following its official approval [2]